Partner Sites

Kephera Diagnostics

Kephera Diagnostics is an innovative medical diagnostics company focused on addressing the global public health challenges arising from emerging infectious diseases

Content by Kephera Diagnostics

Filter by

AllArticleAudioDocumentEventInfographicSurveyVideo
Lyme disease, a tick-transmitted infection that is principally caused by the spirochete Borrelia burgdorferi in the United States and closely related species in Europe, has become the most common vector-borne disease in the US.
|3 min read

New Single-Tier Lyme Disease Test Shows Over 90 Percent Sensitivity in Early Diagnosis

Unlike standard two-tier protocols, the assay uses a dual-antigen binding approach to improve early detection accuracy and may offer a more efficient workflow for clinical labs
byKephera Diagnostics
There are 6.5 million women living with endometriosis in the United States, yet it is still notoriously difficult to diagnose, with a definitive diagnosis taking an average of seven years.
|2 min read

First Blood Test for Endometriosis Now Available in the US

Noninvasive diagnostic offers alternative to surgery and could reduce average 7-year delay in diagnosis for endometriosis
byKephera Diagnostics
PAge with Chagas disease written on it next to a syringe
|2 min read

NIH Awards Grant to Kephera Diagnostics for Congenital Chagas Disease Test

The two year grant will aid in the development of a blood test that measures IgM antibody responses
byKephera Diagnostics
Page 1 of 1
1

Sponsored

Thumbnail

When the Sample Waits: Pre-Analytical Variability in Multi-Analyte Blood Testing

Sponsored by
Clinical scientist working with a clinical analyzer

Protecting Clinical Lab Uptime

Sponsored by
LIVE

Lessons Learned from a Successful Digital Pathology Deployment at CorePath Laboratories

Sponsored by
Hero

Preserving Sample Integrity When Processing is Delayed

Sponsored by